Company / CIK 0001235912
CVRx, Inc.
- Ticker
- CVRX
- Size, estimated from filings
- Micro cap (under $300M)
- Insiders on file
- 16
- Federal contracts on record
- none matched
- Lobbying filings on record
- none matched
- SEC filings
- EDGAR ↗
- Latest trade on record
- August 13, 2026
CVRx, Inc. (CVRX) has 16 insiders on file who disclosed 43 transactions in the last 12 months (3 open-market buys, 12 sales, about $1.1M at reported prices). No federal contract award that started in the last 180 days was found for a recipient with exactly this name; no lobbying filing names it as client this year.
CVRx, Inc. in charts
Who is trading this stock
Which people account for the buying and selling over the last 12 months?
8 people account for the disclosed buying and selling in CVRx, Inc. over the last 12 months; the most active is JOHNSON & JOHNSON with $637K.
Insiders
| Name | Role | Rows | Bought | Sold | Last filed |
|---|---|---|---|---|---|
| Binkowski Brent | CHIEF OPERATING OFFICER | 4 | 1 | 1 | August 13, 2026 |
| Nielsen Kirk G. | Director | 2 | 0 | 0 | June 3, 2026 |
| Jain Mudit K. | Director | 4 | 2 | 0 | June 3, 2026 |
| SLATTERY JOSEPH P | Director | 2 | 0 | 0 | June 3, 2026 |
| Hill, Mitch C. | Director | 2 | 0 | 0 | June 3, 2026 |
| Ballinger Kevin J. | Director | 2 | 0 | 0 | June 3, 2026 |
| SHADAN MARTHA | Director | 2 | 0 | 0 | June 3, 2026 |
| DALE MICHAEL D | Director | 2 | 0 | 0 | June 3, 2026 |
| Adamson Philip B. | Chief Medical Officer | 3 | 0 | 1 | March 16, 2026 |
| Morrison Gregory | CHIEF HUMAN RESOURCES OFFICER | 2 | 0 | 0 | March 4, 2026 |
| John Robert Allen | Chief Revenue Officer | 3 | 0 | 1 | March 3, 2026 |
| OASHEIM JARED | CHIEF FINANCIAL OFFICER | 3 | 0 | 1 | March 3, 2026 |
| VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | 3 | 0 | 1 | March 3, 2026 |
| Hykes Kevin | PRES & CEO | 3 | 0 | 1 | March 3, 2026 |
| GLAXOSMITHKLINE PLC | Insider | 13 | 1 | 0 | December 15, 2025 |
| JOHNSON & JOHNSON | Insider | 6 | 0 | 6 | December 1, 2025 |
Rows are this company's Form 4 rows for each person. "Bought" and "sold" count open-market purchases (code P) and sales only. More in insider buying and insider selling.
Insider transactions
| Filer | Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Binkowski Brent | CVRX | Sell S | August 12, 2026 | August 13, 2026 | 1d | 1,309 | $3 | $3,338 | 10b5-1 plan | Form 4 ↗ | |
| Binkowski Brent | CVRX | Buy P | August 13, 2026 | August 13, 2026 | 0d | 26,223 | $3 | $76K | Form 4 ↗ | ||
| DALE MICHAEL D | CVRX | Other A | June 1, 2026 | June 3, 2026 | 2d | 36,252 | — | — | derivative | Form 4 ↗ | |
| DALE MICHAEL D | CVRX | Other A | June 1, 2026 | June 3, 2026 | 2d | 29,005 | — | — | Form 4 ↗ | ||
| SHADAN MARTHA | CVRX | Other A | June 1, 2026 | June 3, 2026 | 2d | 11,182 | — | — | derivative | Form 4 ↗ | |
| SHADAN MARTHA | CVRX | Other A | June 1, 2026 | June 3, 2026 | 2d | 8,720 | — | — | Form 4 ↗ | ||
| Ballinger Kevin J. | CVRX | Other A | June 1, 2026 | June 3, 2026 | 2d | 11,182 | — | — | derivative | Form 4 ↗ | |
| Ballinger Kevin J. | CVRX | Other A | June 1, 2026 | June 3, 2026 | 2d | 8,720 | — | — | Form 4 ↗ | ||
| Hill, Mitch C. | CVRX | Other A | June 1, 2026 | June 3, 2026 | 2d | 11,182 | — | — | derivative | Form 4 ↗ | |
| Hill, Mitch C. | CVRX | Other A | June 1, 2026 | June 3, 2026 | 2d | 8,720 | — | — | Form 4 ↗ | ||
| SLATTERY JOSEPH P | CVRX | Other A | June 1, 2026 | June 3, 2026 | 2d | 11,182 | — | — | derivative | Form 4 ↗ | |
| SLATTERY JOSEPH P | CVRX | Other A | June 1, 2026 | June 3, 2026 | 2d | 8,720 | — | — | Form 4 ↗ | ||
| Jain Mudit K. | CVRX | Other A | June 1, 2026 | June 3, 2026 | 2d | 11,182 | — | — | derivative | Form 4 ↗ | |
| Jain Mudit K. | CVRX | Other A | June 1, 2026 | June 3, 2026 | 2d | 8,720 | — | — | Form 4 ↗ | ||
| Nielsen Kirk G. | CVRX | Other A | June 1, 2026 | June 3, 2026 | 2d | 11,182 | — | — | derivative | Form 4 ↗ | |
| Nielsen Kirk G. | CVRX | Other A | June 1, 2026 | June 3, 2026 | 2d | 8,720 | — | — | Form 4 ↗ | ||
| Adamson Philip B. | CVRX | Other A | February 27, 2026 | March 16, 2026 | 17d | 62,000 | — | — | late10b5-1 planderivative | Form 4 ↗ | |
| Adamson Philip B. | CVRX | Sell S | March 2, 2026 | March 16, 2026 | 14d | 1,262 | $8 | $9,973 | late10b5-1 plan | Form 4 ↗ | |
| Adamson Philip B. | CVRX | Other A | February 27, 2026 | March 16, 2026 | 17d | 41,000 | — | — | late10b5-1 plan | Form 4 ↗ | |
| Morrison Gregory | CVRX | Other A | March 2, 2026 | March 4, 2026 | 2d | 154,500 | — | — | derivative | Form 4 ↗ | |
| Morrison Gregory | CVRX | Other A | March 2, 2026 | March 4, 2026 | 2d | 34,000 | — | — | Form 4 ↗ | ||
| Hykes Kevin | CVRX | Other A | February 27, 2026 | March 3, 2026 | 4d | 238,000 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| Hykes Kevin | CVRX | Sell S | March 2, 2026 | March 3, 2026 | 1d | 7,763 | $8 | $61K | 10b5-1 plan | Form 4 ↗ | |
| Hykes Kevin | CVRX | Other A | February 27, 2026 | March 3, 2026 | 4d | 159,000 | — | — | 10b5-1 plan | Form 4 ↗ | |
| VERRASTRO PAUL | CVRX | Other A | February 27, 2026 | March 3, 2026 | 4d | 67,000 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| VERRASTRO PAUL | CVRX | Sell S | March 2, 2026 | March 3, 2026 | 1d | 1,284 | $8 | $10K | 10b5-1 plan | Form 4 ↗ | |
| VERRASTRO PAUL | CVRX | Other A | February 27, 2026 | March 3, 2026 | 4d | 45,000 | — | — | 10b5-1 plan | Form 4 ↗ | |
| OASHEIM JARED | CVRX | Other A | February 27, 2026 | March 3, 2026 | 4d | 91,000 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| OASHEIM JARED | CVRX | Sell S | March 2, 2026 | March 3, 2026 | 1d | 1,744 | $8 | $14K | 10b5-1 plan | Form 4 ↗ | |
| OASHEIM JARED | CVRX | Other A | February 27, 2026 | March 3, 2026 | 4d | 61,000 | — | — | 10b5-1 plan | Form 4 ↗ | |
| John Robert Allen | CVRX | Other A | February 27, 2026 | March 3, 2026 | 4d | 52,000 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| John Robert Allen | CVRX | Sell S | March 2, 2026 | March 3, 2026 | 1d | 3,964 | $8 | $31K | 10b5-1 plan | Form 4 ↗ | |
| John Robert Allen | CVRX | Other A | February 27, 2026 | March 3, 2026 | 4d | 35,000 | — | — | 10b5-1 plan | Form 4 ↗ | |
| Binkowski Brent | CVRX | Other A | February 27, 2026 | March 3, 2026 | 4d | 23,000 | — | — | derivative | Form 4 ↗ | |
| Binkowski Brent | CVRX | Other A | February 27, 2026 | March 3, 2026 | 4d | 15,000 | — | — | Form 4 ↗ | ||
| Jain Mudit K. | CVRX | Buy P | February 20, 2026 | February 23, 2026 | 3d | 46,800 | $6 | $298K | indirect | Form 4 ↗ | |
| Jain Mudit K. | CVRX | Buy P | February 18, 2026 | February 18, 2026 | 0d | 600 | $5 | $2,785 | Form 4 ↗ | ||
| JOHNSON & JOHNSON | CVRX | Sell S | November 26, 2025 | December 1, 2025 | 5d | 6,337 | $10 | $64K | lateindirect | Form 4 ↗ | |
| JOHNSON & JOHNSON | CVRX | Sell S | November 24, 2025 | November 25, 2025 | 1d | 2,200 | $10 | $22K | indirect | Form 4 ↗ | |
| JOHNSON & JOHNSON | CVRX | Sell S | November 21, 2025 | November 25, 2025 | 4d | 500 | $10 | $5,000 | indirect | Form 4 ↗ | |
| JOHNSON & JOHNSON | CVRX | Sell S | November 12, 2025 | November 14, 2025 | 2d | 1,000 | $10 | $10K | indirect | Form 4 ↗ | |
| JOHNSON & JOHNSON | CVRX | Sell S | November 7, 2025 | November 10, 2025 | 3d | 200 | $10 | $2,000 | indirect | Form 4 ↗ | |
| JOHNSON & JOHNSON | CVRX | Sell S | November 6, 2025 | November 10, 2025 | 4d | 52,332 | $10 | $534K | indirect | Form 4 ↗ | |
| GLAXOSMITHKLINE PLC | CVRX | Exchange C | July 2, 2021 | July 6, 2021 | 4d | 10,055,408 | — | — | indirectderivative | Form 4 ↗ | |
| GLAXOSMITHKLINE PLC | CVRX | Exchange C | July 2, 2021 | July 6, 2021 | 4d | 1,081,434 | — | — | indirectderivative | Form 4 ↗ | |
| GLAXOSMITHKLINE PLC | CVRX | Exchange C | July 2, 2021 | July 6, 2021 | 4d | 331,399 | — | — | indirectderivative | Form 4 ↗ | |
| GLAXOSMITHKLINE PLC | CVRX | Exchange C | July 2, 2021 | July 6, 2021 | 4d | 589,939 | — | — | indirectderivative | Form 4 ↗ | |
| GLAXOSMITHKLINE PLC | CVRX | Exchange C | July 2, 2021 | July 6, 2021 | 4d | 513,312 | — | — | indirectderivative | Form 4 ↗ | |
| GLAXOSMITHKLINE PLC | CVRX | Exchange C | July 2, 2021 | July 6, 2021 | 4d | 59,527 | — | — | indirectderivative | Form 4 ↗ | |
| GLAXOSMITHKLINE PLC | CVRX | Buy P | July 2, 2021 | July 6, 2021 | 4d | 275,000 | $18 | $5.0M | indirect | Form 4 ↗ | |
| GLAXOSMITHKLINE PLC | CVRX | Exchange C | July 2, 2021 | July 6, 2021 | 4d | 635,646 | — | — | indirect | Form 4 ↗ | |
| GLAXOSMITHKLINE PLC | CVRX | Exchange C | July 2, 2021 | July 6, 2021 | 4d | 27,345 | — | — | indirect | Form 4 ↗ | |
| GLAXOSMITHKLINE PLC | CVRX | Exchange C | July 2, 2021 | July 6, 2021 | 4d | 8,380 | — | — | indirect | Form 4 ↗ | |
| GLAXOSMITHKLINE PLC | CVRX | Exchange C | July 2, 2021 | July 6, 2021 | 4d | 14,917 | — | — | indirect | Form 4 ↗ | |
| GLAXOSMITHKLINE PLC | CVRX | Exchange C | July 2, 2021 | July 6, 2021 | 4d | 12,979 | — | — | indirect | Form 4 ↗ | |
| GLAXOSMITHKLINE PLC | CVRX | Exchange C | July 2, 2021 | July 6, 2021 | 4d | 1,505 | — | — | indirect | Form 4 ↗ |
Federal contracts (USAspending, awards started in the last 180 days)
No contract award starting in the last 180 days was found for a recipient named exactly "CVRx, Inc.". Subsidiaries and differently-spelled recipients are not matched — search contracts.
Lobbying (Senate LDA, as client)
No LDA filing posted since October 2025 names "CVRx, Inc." as the client. Filings under a subsidiary or trade-association name are not matched — search lobbying.
Related companies
Companies whose stock was traded by the same people who traded CVRX, by number of filers in common. It shows overlap in public filings and nothing else.
- Wave Life Sciences, Inc. WVE 1 filer in common
- BICYCLE THERAPEUTICS PLC BCYC 1 filer in common
- Innoviva, Inc. INVA 1 filer in common
- Lyell Immunopharma, Inc. LYEL 1 filer in common
- Decibel Therapeutics, Inc. DBTX 1 filer in common
- GENOCEA BIOSCIENCES, INC. GNCA 1 filer in common
- Theravance Biopharma, Inc. TBPH 1 filer in common
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 23 | 56 | July 6, 2021 | August 13, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Insiders and their transactions come from SEC EDGAR Form 4 filings for this issuer. Contracts and lobbying are matched by exact normalized name (suffixes like Inc./Corp. ignored) to USAspending recipients and LDA clients — a conservative match that misses subsidiaries on purpose. See methodology and corrections.
Not investment advice. Public records shown as filed; no recommendation is made or implied.